- JP-listed companies
- CanBas Co.,Ltd.
- Financials
- Capital expenditures
CanBas Co.,Ltd. (4575)
Market cap
¥14.8B
P/E ratio
Canvas is a biotech company that discovers and develops cancer drugs using its proprietary platform, from early research through clinical trials.
| Period End | Capital expenditures (Million JPY) | YoY (%) |
|---|---|---|
| Jun 30, 2016 | -13 | +2426.42% |
| Jun 30, 2015 | -1 | -15.87% |
| Jun 30, 2014 | -1 |